---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013881"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-09-17T23:59:59+00:00"
generated_at: "2026-05-17T06:20:35.269002+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix prices $2M registered direct offering of common stock and prefunded warrants at $7.01

## Summary
- Offering of 74,114 common shares and prefunded warrants for 217,090 shares at $7.01 per share (or $7.009 per warrant).
- Gross proceeds of ~$2.0M; net proceeds ~$1.8M after placement fees and expenses.
- Proceeds to be used for working capital, repayment of debt and/or redemption of preferred stock.
- Palladium Capital Group acted as exclusive placement agent; closing expected September 17, 2025.

## SEC filing metadata
- accession: 0001493152-25-013881
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-09-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315225013881/0001493152-25-013881-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315225013881/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013881
- JSON: https://secwatch.observer/filing/0001493152-25-013881.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013881.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.